I

n a bid to pull the curtain back on drug pricing, Senator Ron Wyden (D-Ore.) introduced a bill Wednesday that would require pharmacy benefit managers to disclose information about the controversial rebates paid by drug makers to win coveted spots on health plan formularies.

The legislation would force pharmacy benefit managers, which are the middlemen that negotiate prices between drug makers and health plans, to publicly post aggregated data about rebates and discounts that are obtained on behalf of Medicare Part D and Medicare Advantage plans.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.